IDV vehicle

36E79725D0009

2 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC PHARMACEUTICALS (36E797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$100.5M
Start dateFeb 26, 2025
Current end dateNot available
Potential end dateNot available
Latest award activityJan 28, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 28, 2026P00003$0EXERCISE OPTION YEAR 1 WITH NO PRICE CHANGES
Jan 12, 2026P00002$02026 SUBCONTRACTING PLAN
Dec 3, 2025P00001$02026 PUBLIC LAW PRICING UPDATES
Jan 13, 20250$02 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Christopher CarthronContract SpecialistChristopher.Carthron@va.govSourceOct 31, 2024
Christopher CarthronContract SpecialistChristopher.Carthron@va.govSourceOct 15, 2024
Christopher CarthronContract SpecialistChristopher.Carthron@va.govSourceOct 8, 2024
Chris CarthronContracting OfficerChristopher.Carthron@va.gov
(708) 708-786-4980
SourceSep 25, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.